[11] The previous term PCOS was considered "inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing." The new term reflects "the condition's multisystem pathophysiology", and is more accurate by omitting cysts
The success of GLP-1 agonists in helping people lose weight Since GLP-1 agonist medications were first approved by the FDA about a decade ago to control diabetes, the weight loss effects have been impressive, prompting the FDA to expand its approval to include obesity
sAC was, however, detected in unbound fractions
Data analysis Data shown are the means standard error of the mean
Do you currently assess your patients for a preexisting history of an eating disorder